CHOP experts in bleeding disorders care and research presented at the American Society of Hematology 2022 conference.

This “multimodal” analysis helps reveal relationships between different aspects of a cell and how they might impact disease development.

A study involving CHOP researchers found that a weekly dose of dupilumab, a monoclonal antibody, led to a reduction of symptoms and tissue improvement in young adults and adolescents with eosinophilic esophagitis (EoE).

Nearly 50 faculty, staff and trainees from the Division of Hematology and Division of Oncology at Children’s Hospital of Philadelphia attended the 64th Annual American Hematology Society (ASH) Meeting in New Orleans, Louisiana.

For more than 50 years, Children’s Hospital of Philadelphia has been on the forefront of astounding advances in HI that have saved lives and improved lifetimes.

J. Yvener Deverlis went to to the Dominican Republic as part of the CHOP Global Allies Program to help teach local health promotors. He ended up learning even more.

An update on our first Education Day in November and more.

Youth with chronic conditions like spina bifida and their families can experience high levels of stress.

Meet Matthew O’Connor, MD, Medical Director of the Heart Failure and Transplant Program at Children’s Hospital of Philadelphia (CHOP).

The experiences international observers have at Children's Hospital of Philadelphia allow clinicians from countries across the globe to make incredible changes in their own countries.